Table 2.
The number of interactions between miRNAs and mRNAs, miRNA families and the miRNAs and mRNAs (i.e., genes) linked to better RFS and OS with reference to enriched pathways.
Pathways | Interactions (miRNA‐mRNA) | Pancreatobiliary prognostic markers (miRNA and mRNA) | Intestinal prognostic markers (miRNA and mRNA) | miRNA family |
---|---|---|---|---|
Insulin regulation and recycling | 175 (40–45) | CALM1, PCK2, SLC2A4, PDPK1, PPARGC1A, PIK3R1, PHKB, hsa‐miR‐196b, hsa‐miR‐497 | FBP1, G6PC, PCK2, PIK3R2, PDPK1, hsa‐miR‐424, hsa‐miR‐382, hsa‐miR‐127‐3p, hsa‐miR‐193b*, hsa‐miR‐365, hsa‐miR‐455‐3p, hsa‐miR‐335 | miR‐192, miR‐194, miR‐196, miR‐17, miR‐18, miR‐19, miR‐194, miR‐199, miR‐99, miR‐329 |
Wnt signaling | 163 (40–38) | LRP6, CXXC4, PPARD, CCND2, hsa‐miR‐196b, hsa‐miR‐497, has‐miR‐592 | WNT5A, CAMK2G, VANGL1, NFATC4, hsa‐miR‐455‐3p, hsa‐miR‐335, hsa‐miR‐193b*, hsa‐miR‐365, hsa‐miR‐424, hsa‐miR‐127‐3p | miR‐192, miR‐194, miR‐196, miR‐17, miR‐18, miR‐19, miR‐194, miR‐199, miR‐99, miR‐154 |
E2F | 162 (43–27) | RB1, ATM,E2F7 | E2B2, CEBPA, hsa‐miR‐193b*, hsa‐miR‐365, hsa‐miR‐654‐3p, hsa‐miR‐424, hsa‐miR‐127‐3p, hsa‐miR‐377*, hsa‐miR‐455‐3p, hsa‐miR‐335 | miR‐192, miR‐194, miR‐196, miR‐17, miR‐18, miR‐19, miR‐194, miR‐199, miR‐99, miR‐154 |
PPAR | 150 (44–38) | PIK3R1, RB1, RXRA, PCK2, PDPK1, PPARD, PTGS2 | miR‐192, miR‐194, miR‐196, miR‐17, miR‐18, miR‐19, miR‐194, miR‐199, miR‐99, miR‐154, miR‐329 | |
p73 | 117 (43–23) | BBC3, WT1, GATA1, RB1, ITCH | hsa‐miR‐193b*, hsa‐miR‐654‐3p, hsa‐miR‐424, hsa‐miR‐127‐3p, hsa‐miR‐335 | miR‐192, miR‐194, miR‐196, miR‐17, miR‐18, miR‐19, miR‐194, miR‐199, miR‐99, miR‐154, miR‐329 |
ATM | 107 (43–12) | ATM, hsa‐miR‐196b, hsa‐miR‐497 | hsa‐miR‐365, hsa‐miR‐654‐3p, hsa‐miR‐424, hsa‐miR‐127‐3p, hsa‐miR‐377*, hsa‐miR‐455‐3p, hsa‐miR‐335 | miR‐192, miR‐194, miR‐196, miR‐17, miR‐18, miR‐19, miR‐194, miR‐199, miR‐99, miR‐154 |
p53 | 76 (46–17) | RB1, PTEN, BBC3, hsa‐miR‐196b, hsa‐miR‐497, has‐miR‐592 | GADD45B, hsa‐miR‐485‐3p, hsa‐miR‐193b*, hsa‐miR‐365, hsa‐miR‐654‐3p, hsa‐miR‐424, hsa‐miR‐127‐3p, hsa‐miR‐377*, hsa‐miR‐455‐3p, hsa‐miR‐335 | miR‐192, miR‐194, miR‐196, miR‐17, miR‐18, miR‐19, miR‐194, miR‐199, miR‐99, miR‐154, miR‐329 |
Interferon/cytokine | 66 (29–14) | hsa‐miR‐196b, hsa‐miR‐497 | hsa‐miR‐377*, hsa‐miR‐455‐3p, hsa‐miR‐424, hsa‐miR‐365 | miR‐192, miR‐194, miR‐196, miR‐17, miR‐18, miR‐19, miR‐194, miR‐199, miR‐99 |
RB1 | 44 (25–7) | RB1, hsa‐miR‐497 | hsa‐miR‐193b*, hsa‐miR‐365, hsa‐miR‐654‐3p, hsa‐miR‐424, hsa‐miR‐127‐3p, hsa‐miR‐377*, hsa‐miR‐455‐3p, hsa‐miR‐335 | miR‐192, miR‐194, miR‐17, miR‐18, miR‐19, miR‐194, miR‐199, miR‐99 |
Phosphatidyl‐inosiol signaling | 42 (27–7) | PIK3R1, CALM1, ITPR1, has‐miR‐497 | PIK3R2, INPPL1, hsa‐miR‐335, hsa‐miR‐424 | miR‐192, miR‐17, miR‐18, miR‐19, miR‐194, miR‐199, miR‐99, miR‐329 |
DNA repair | 27 (16–9) | FANCG, ATM | hsa‐miR‐335, hsa‐miR‐424 | miR‐192, miR‐17, miR‐18, miR‐19, miR‐154 |
ATR | 19 (13–10) | – | – | miR‐192, miR‐17, miR‐18, miR‐19, miR‐196, miR‐99 |
Glycolysis and Gluconeogenesis | 6 (4–5) | FBP1, G6PC, ALDH9A1 | – |